Publication | Closed Access

β1 antagonist and β2 agonist, celiprolol, restores the impaired endothelial dependent and independent responses and decreased TNFα in rat with type II diabetes

InflammationMetabolic SyndromeMedicineVascular PharmacologyDiabetesPhysiologyImmunologyβ1 AntagonistEndothelial DysfunctionVascular Biologyβ2 AgonistPharmacologyType Ii DiabetesHealth Sciences